Posts Tagged ‘blog carnival’

Trying to get it right: a blog carnival about Right to Try

Author: Stacey Johnson, 08/29/17

The crux of Right to Try legislation, enacted by 37 U.S. states so far, is the premise that terminally ill patients should have access to experimental therapies, even if they haven’t been approved by the Food and Drug Administration yet. It sounds straight-forward right? My body, my risk, my decision. The U.S. already has measures…Read more

Valuing the good, the bad and the ugly

Author: David Kent, 08/29/17

As with all of my posts that relate to anything that might end up being a medical treatment, it is important to be very clear that I am scientist and not a physician.  My comments are my own opinion and based on my experience as a stem cell biologist over the last 10+ years. This…Read more

A prescription of hope

Author: Guest, 08/29/17

By Brian Sladek I am honoured to have my blog be just one of several covering this topic as part of Signal’s second annual blog carnival on the theme ‘Right to Try.’ Please click here to read what other bloggers think of this. As a patient, I don’t care about percentages. According to a recent SEER…Read more

An ivory tower perspective of the right-to-try movement: We need to balance the equation

Author: Guest, 08/29/17

Patrick Bedford is the Senior Manager of Clinical Translation and Regulatory Affairs at CCRM. He holds a Master’s Degree in Bioethics and Health Law, and a Regulatory Affairs Certificate. Patrick has spent over 11 years applying federal regulations to emerging biotechnologies in Canada. Follow him on LinkedIN. Do desperate times call for desperate measures in the context…Read more

Weighing in on a controversial topic

Author: Stacey Johnson, 08/23/17

We are less than one week away from Signals’ second blog carnival! Last month I promised to reveal the topic and the participants. I also hinted that this year’s topic might strike some readers as controversial. Given that a few invited bloggers declined to participate, I’d have to say that’s the case. So although our…Read more

Right Turn: Vacationing on Mars

Author: Stacey Johnson, 08/18/17

Hi Loyal Readers, Happy summer! Thanks for your visits all year. I’m on vacation this week, but I thought I’d leave you with something anyway. Next week, I’ll provide some more details about the upcoming blog carnival taking place August 29th. I hope you’ll drop by to read all the interesting blogs and different points…Read more

The stem cell community’s blog carnival is back!

Author: Stacey Johnson, 07/27/17

Last August, Signals hosted its first blog carnival and it was so much fun, we’re doing it again. Missed it? No idea what a blog carnival involves? The way I explained it last year is like this: A blog carnival is essentially an online blogging “party” with many guests who all blog on the same…Read more

Right Turn: My favourite things (blogs!)

Author: Stacey Johnson, 12/30/16

  Raindrops on roses and whiskers on kittens, Bright copper kettles and warm woolen mittens, Brown paper packages tied up with strings, Blogs are a few of my favourite things. When the dog bites, When the bee stings, When I’m feeling sad, I simply remember my favourite blogs and then I don’t feel so bad….Read more

A complete (re)program to recognize the 10-year anniversary of iPSCs

Author: Stacey Johnson, 08/25/16

Ten years ago today, Japanese scientists Shinya Yamanaka and Kazutoshi Takahashi published a paper announcing the creation of rodent induced pluripotent stem (iPS) cells, thus pioneering the field of iPS cell technology. They showed that they could convert adult cells into pluripotent stem cells – in other words, they reprogrammed them to look and function…Read more

iPS cell technology – kickstarting our ability to control cell identity

Author: Holly Wobma, 08/25/16

When you hear the word “stem cell,” I imagine this conjures up the image of cells that are special. Unlike most cells, stem cells can differentiate into other cell types. They hold the promise of curing many diseases, and thus they are continually the source of hype in mainstream and social media. Yet the above…Read more